3858 results for «2285»

Filter By

3858 results

Lifetime management of patients with severe aortic stenosis

22 Nov 2021 – From PCR London Valves

Don't miss this PCR London Valves 2021 session if you wish to discuss the importance of lifetime management in patients with severe aortic stenosis, to learn about the latest CoreLab adjudicated outcomes from the Early neo2 registry, and to understand how valve design, implant technique, embolic...

Lifetime management of patients with severe aortic stenosis

Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform

23 Nov 2021 – From PCR London Valves

Explore the clinical impact of the Edwards portfolio of transcatheter devices for mitral regurgitation treatment in this PCR London Valves 2021 session that you shouldn't miss if you want to attend case-based discussions that will analyze key PASCAL features to treat mitral regurgitation and to participate...

Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform

From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options

21 Nov 2021 – From PCR London Valves 2021

Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned. Bernard Prendergast, Philipp Lurz, Fabien Praz and Maurizio Taramasso discuss the challenges and needs regarding mitral and tricuspid valve disease treatment. They also consider what is needed to...

From TAVI to mitral and

From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options - Part 1 - Best long-term outcomes start with the first procedure

21 Nov 2021 – From PCR London Valves

In this session from PCR London Valve 2021 dedicated to TAVI, mitral, and tricuspid, let's examine the issues related to the lifetime patient journey faced by many patients, starting with an analysis of severe aortic stenosis: how to identify the most important factors when considering the...

From TAVI to mitral and tricuspid - Part 1 - Best long-term outcomes start with the first procedure

From TAVI to mitral and tricupid - Applying evidence to expand patients' treatment options - Part 2 - Securing long-term patient options

22 Nov 2021 – From PCR London Valves

Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned, as you can notice in this session broadcast at PCR London Valves 2021 Congress, focusing on this topic area. Watch it now if you wish to understand how key...

From TAVI to mitral and tricupid - Part 2 - Securing long-term patient options

PCR London Valves 2021 Hotlines / Late-Breaking Trials: GALILEO, JenaValve TAVI, ENVISAGE TAVI AF, VKA in patients with AF after TAVI

21 Nov 2021 – From PCR London Valves 2021

In this session, find out more about the JenaValve TAVI system in patients with aortic regurgitation, get results from the GALILEO trial, review a late-breaking on-treatment major bleeding analysis from the ENVISAGE TAVI AF trial, and explore the safety and efficacy of edoxaban versus VKA in patients with AF...

PCR London Valves 2021 Hotlines / Late-Breaking Trials: GALILEO, JenaValve TAVI,, ENVISAGE TAVI AF, VKA in patients with AF after TAVI

Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation

25 Jun 2020 – From PCR e-Course 2020

A  common  exclusion  for  transcatheter  mitral  valve  implantation  (TMVI)  is  a  small  predicted  neo-left  ventricular  outflow  tract  (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...

LVESD screening determines anatomic suitability for TMVI

New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection

26 Jun 2020 – From PCR e-Course 2020

Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.

New TMVI Therapy to eliminate mitral regurgitation: evidence and patient selection

Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation

Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.

Videos included on this page: the Hot Line presentation and...

Two-year outcomes of

Shaping care pathways for severe aortic stenosis patients in a COVID-19 context

Watch this roundtable discussion on the management of aortic stenosis in the context of the COVID-19 pandemic and how to readdress the treatment options and pathways to serve the needs of the patients in this difficult global crisis.

Shaping care pathways for severe aortic stenosis patients in a COVID-19 context

Portico FlexNav - Optimise TAVI outcomes from routine to complex cases

Watch this session if you want to learn how Portico enables you to achieve favorable haemodynamics and patient outcomes, to learn about the new Portico with FlexNav TAVI system and its deliverability and to learn the importance of looking ahead during transcatheter aortic valve implantation and...

Portico FlexNav - Optimise TAVI outcomes from routine to complex cases

PCR e-Course 2020 Late-Breaking Trials – part 1

26 Jun 2020 – From PCR e-Course 2020

Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice: 

  • Crossover results from the RADIANCE-HTN SOLO trial
  • DynamX Bioadaptor, a novel « uncaging » platform
  • Two-stent vs. provisional for bifurcation PCI: the DEFINITION II trial
PCR e-Course 2020 Late-Breaking Trials

PCR e-Course 2020 Hot lines: TAVI – part 2

26 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: PORTICO IDE, FlexNav Delivery System, FRANCE TAVI, BIVOLUT-X, VIVALL.

Hot lines: TAVI

Hot lines on Mitral interventions – part 1

25 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on mitral interventions presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: EVOQUE replacement, Tendyne TMVI, CLASP, V-i-V and V-i-R, Tendyne MAC.

Hot Lines on mitral interventions

Revascularisation strategies - PCR e-Course 2020 Hot lines

29 Jul 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on revascularisation presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: ISIS II, REDUCER-I, RINCAL, SYNTAX score II 2020.

Revascularisation strategies

PCR e-Course Hot lines on TAVI – part 1

25 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: Evolut Low-Risk trial, MyVal-1 study, BASILICA vs. control, non-invasive ultrasound therapy, long-term outcomes after V-i-V.

Hotlines on TAVI

Hot lines on tricuspid interventions

Watch a series of Hot Lines on repair techniques for tricuspid regurgitation presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: Transferomal TTVR with EVOQUE, STTAR, TRILUMINATE.

Hot lines on tricuspid interventions

CT guidance for coronary interventions - PCR e-Course 2020 Hot lines

26 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on CT-guidance for PCI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: CT-FFR CHINA, CAST-FFR, CT-QFR vs. myocardial perfusion imaging, CT-CTO trial, CCTA for optimal fluoroscopic coronary projections.

CT guidance for coronary interventions

FFR wires passé? Rethinking the physiological assessment of coronary artery disease

25 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to identify hemodynamic relevance of intermediate coronary lesions with highest diagnostic accuracy to allow individualized therapy and to learn about the new technology of coronary angiography derived FFR & its clinical potential.

FFR wires passé? Rethinking the physiological assessment of coronary artery disease

Abstracts on STEMI - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of abstracts from PCR e-Course 2020 on the topic of STEMI:

  • Thromboresistance of DES in a swine shunt model under clopidogrel monotherapy
  • PICSO improves coronary microvascular function in patients with STEMI
Abstracts on STEMI - PCR e-Course 2020
Didn’t find what you were looking for?